National Marrow Donor Program Session: Donor Issues

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 1 SUPPL., 2013, Pages

  Navarro, Willis H ^a   Switzer, Galen E ^b   Pulsipher, Michael ^c  

^a NATIONAL MARROW DONOR PROGRAM   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANOREXIA; APHERESIS; ARTHRALGIA; ARTICLE; BACKACHE; BONE MARROW TRANSPLANTATION; BONE PAIN; DIZZINESS; DRUG EFFECT; FAINTNESS; FATIGUE; FEVER; HEADACHE; HEMATOPOIETIC STEM CELL; HIP PAIN; HUMAN; INJECTION SITE PAIN; INSOMNIA; LIMB PAIN; MYALGIA; NAUSEA; NECK PAIN; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RASH; SORE THROAT; VOMITING;

ADULT; DONOR SELECTION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; RECOMBINANT PROTEINS; REGISTRIES; SAFETY; UNRELATED DONORS;

EID: 84871891402     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.10.019     Document Type: Article

References (27)

1. Pulsipher M.A., Chitphakdithai P., Miller J.P., et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood 2009, 113:3604-3611.
2. Miller J.P., Perry E.H., Price T.H., et al. Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program. Biol Blood Marrow Transplant 2008, 14:29-36.
3. Holig K., Kramer M., Kroschinsky F., et al. Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood 2009, 114:3757-3763.
4. Styczynski J., Balduzzi A., Gil L., et al. Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective EBMT-PDWP study. Blood 2011, 119:2935-2947.
5. Pulsipher M.A., Levine J.E., Hayashi R.J., et al. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the Pediatric Blood and Marrow Transplant Consortium (PBMTC) experience, 1996-2003. Bone Marrow Transplant 2005, 35:361-367.
6. Lysak D., Koristek Z., Gasova Z., et al. Efficacy and safety of peripheral blood stem cell collection in elderly donors: does age interfere?. J Clin Apher 2011, 26:9-16.
7. Rowley S.D., Donaldson G., Lilleby K., et al. Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation. Blood 2001, 97:2541-2548.
8. Favre G., Beksac M., Bacigalupo A., et al. Differences between graft product and donor side effects following bone marrow or stem cell donation. Bone Marrow Transplant 2003, 32:873-880.
9. Siddiq S., Pamphilon D., Brunskill S., et al. Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors. Cochrane Database Syst Rev 2009, CD006406.
10. Pulsipher M.A., Chitphakdithai P., Logan B.R., et al. Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the NMDP. Blood 2012, [Epub ahead of print].
11. Bortin M.M., Buckner C.D. Major complications of marrow harvesting for transplantation. Exp Hematol 1983, 11:916-921.
12. Buckner C.D., Clift R.A., Sanders J.E., et al. Marrow harvesting from normal donors. Blood 1984, 64:630-634.
13. Confer D., Miller J., Chell J.W. Bone marrow and peripheral blood cell donors and donor registries. Thomas' Hematopoietic Cell Transplantation 2004, 544-558. Oxford, UK: Blackwell. F.R. Appelbaum, S.J. Forman, R.S. Negrin (Eds.).
14. Switzer G.E., Dew M.A., Stukas A.A., et al. Factors associated with attrition from a national bone marrow registry. Bone Marrow Transplant 1999, 24:313-319.
15. Bolan C.D., Hartzman R.J., Perry E.H., et al. Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program. Biol Blood Marrow Transplant 2008, 14:23-28.
16. Rinaldi C., Savignano C., Pasca S., et al. Efficacy and safety of peripheral blood stem cell mobilization and collection: a single-center experience in 190 allogeneic donors. Transfusion 2012, 52:2367-2394.
17. NMDP. Program Data. Available at: 2012. http://www.marrow.org/Physicians/Outcomes_Data/Outcomes_Data.aspx#number.
18. Avalos B.R., Lazaryan A., Copelan E.A. Can G-CSF cause leukemia in hematopoietic stem cell donors?. Biol Blood Marrow Transplant 2011, 17:1739-1746.
19. Bennett C.L., Evens A.M., Andritsos L.A., et al. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol 2006, 135:642-650.
20. Martino M., Fedele R., Massara E., et al. Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?. Expert Opin Biol Ther 2012, 12:609-621.
21. McCullough J., Kahn J., Adamson J., et al. Hematopoietic growth factors-use in normal blood and stem cell donors: clinical and ethical issues. Transfusion 2008, 48:2008-2025.
22. Mueller M.M., Bialleck H., Bomke B., et al. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study. Vox Sang 2012, [Epub ahead of print].
23. Pulsipher M.A., Nagler A., Iannone R., et al. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatr Blood Cancer 2006, 46:422-433.
24. Schmidt A.H.M.T., Pingel J., Rall G., et al. Follow-up of 12,559 unrelated donors of peripheral blood stem cells or bone marrow. Blood (ASH Annual Meeting Abstracts) 2010, 116:365a.
25. Nagler A., Korenstein-Ilan A., Amiel A., et al. Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells. Exp Hematol 2004, 32:122-130.
26. Hirsch B., Oseth L., Cain M., et al. Effects of granulocyte-colony stimulating factor on chromosome aneuploidy and replication asynchrony in healthy peripheral blood stem cell donors. Blood 2011, 118:2602-2608.
27. + cells and does not require cell division. Blood 2010, 115:910-911.